Tests treatment safety and results for Primary Care
Official title Effectiveness of a Joint General Practitioner-Pharmacist Intervention on Benzodiazepine Deprescribing in the Elderly
ClinicalTrials.gov ID: NCT05765656
What this study is testing
- What it's testing
- Benzodiazepines or related drug (BZDR) are consumed for hypnotic or anxiolytic purposes in most cases. The consequences of BZDR are multiple with an increased risk of daytime sedation, balance disorders leading to falls and fractures, cognitive disorders, road accidents and dementia.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- outpatients aged 65 and over
- followed by the general practitioner and the pharmacist of the GP-PO pair
- having a prescription for an anxiolytic or hypnotic BZDR prescribed at least 4 times in the past year
- the last prescription being less than 3 months old
- having been dispensed monthly during the last 3 months
You likely can't join if
- patients living in an institution
- participating in a clinical trial
- with epilepsy
- active depression
- uncontrolled mental disorders
- unable to participate in an interview or answer a questionnaire (demented, non-French speaking, illiterate, deaf, ...)
See the full eligibility criteria
- outpatients aged 65 and over
- followed by the general practitioner and the pharmacist of the GP-PO pair
- having a prescription for an anxiolytic or hypnotic BZDR prescribed at least 4 times in the past year
- the last prescription being less than 3 months old
- having been dispensed monthly during the last 3 months
- affiliated to a social security scheme
- and having given consent to participate in the research.
- patients living in an institution
- participating in a clinical trial
- with epilepsy
- active depression
- uncontrolled mental disorders
- unable to participate in an interview or answer a questionnaire (demented, non-French speaking, illiterate, deaf, ...)
- under guardianship
- with a dystonic syndrome
- and patients who are not sufficiently autonomous to carry out the steps inherent in the study
The study team makes the final eligibility decision.
Where it's taking place
- Nantes, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nantes, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.